EPHA3 and neoplasm: IHC analysis of tumours showed that those from EphA3 shRNA mice displayed significantly less staining of the endothelial marker CD31, indicative of reduced tumour angiogenesis, with a concomitant decrease in proliferation, as determined by Ki67 staining (Figure 5D).